Change in Auditors ASPEN PHARMACARE HOLDINGS LIMITED (Incorporated in the Republic of South Africa) (“Aspen Holdings”) Registration number: 1985/002935/06 Share code: APN ISIN: ZAE000066692 LEI: 635400ZYSN1IRD5QWQ94 and its subsidiaries (collectively “Aspen” or “the Group”) CHANGE IN AUDITORS In May 2019 the Aspen Audit & Risk Committee embarked on a “Request for Proposals” process in respect of external audit services. Following the conclusion of this process, the Audit & Risk Committee has recommended, and the Board has endorsed, the proposed appointment of Ernst & Young Inc. (EY) as the auditors of Aspen for the financial year ending 30 June 2021. The Audit & Risk Committee has also confirmed the appointment of Motlanalo Inc. (Motlanalo) to undertake the audit of the Fine Chemicals Corporation (Pty) Limited and the joint audit (with EY) of Aspen Pharmacare Limited (both wholly owned South African subsidiaries of Aspen Holdings). This appointment of EY will be put to the shareholders of Aspen at the annual general meeting scheduled for 9 December 2020. PwC is in the process of concluding its audit of Aspen’s accounts in respect of the financial year ended 30 June 2020 and will step down as auditors following the issuance of its report in respect of this year. Durban 11 September 2020 Sponsor Investec Bank Limited Date: 11-09-2020 04:32:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.